243 related articles for article (PubMed ID: 30398019)
1. Mortality in autoimmune rheumatic diseases with anti-Ro/SSA antibody in Korea: Single center-based retrospective study.
Kim SK; Choe JY; Kwak SG
Int J Rheum Dis; 2019 Feb; 22(2):191-199. PubMed ID: 30398019
[TBL] [Abstract][Full Text] [Related]
2. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
3. Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine.
Senécal JL; Chartier S; Rothfield N
J Rheumatol; 1995 May; 22(5):868-75. PubMed ID: 8587074
[TBL] [Abstract][Full Text] [Related]
4. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
[TBL] [Abstract][Full Text] [Related]
5. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
6. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
[TBL] [Abstract][Full Text] [Related]
7. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases.
García-de la Torre I; Sánchez-Guerrero A; Salmón-de la Torre G; Hernández-Vázquez L
J Rheumatol; 1987 Jun; 14(3):479-81. PubMed ID: 3498034
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
11. Initial presentation determines clinical entity in patients with anti-centromere antibody positivity.
Tsukamoto M; Suzuki K; Takeuchi T
Int J Rheum Dis; 2019 Jan; 22(1):103-107. PubMed ID: 30428504
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
Sulcebe G; Morcka K
Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
[TBL] [Abstract][Full Text] [Related]
14. Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy?
Böckle BC; Stanarevic G; Ratzinger G; Sepp NT
Br J Dermatol; 2012 Nov; 167(5):1067-75. PubMed ID: 22816490
[TBL] [Abstract][Full Text] [Related]
15. Predicting Sjögren's syndrome in patients with recent-onset SLE.
Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of mothers of children with complete congenital heart block.
Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
[TBL] [Abstract][Full Text] [Related]
17. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
[TBL] [Abstract][Full Text] [Related]
18. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
Breda L; Nozzi M; De Sanctis S; Chiarelli F
Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
[TBL] [Abstract][Full Text] [Related]
19. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.
Lloyd TE; Christopher-Stine L; Pinal-Fernandez I; Tiniakou E; Petri M; Baer A; Danoff SK; Pak K; Casciola-Rosen LA; Mammen AL
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):66-71. PubMed ID: 25892010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
